DGAP-News: A Brighter Decade Ahead for Biotech - Industry Report Featuring Sareum Holdings Plc and Angel Biotechnology Holdings Plc
ID: 359831
Prognose/Sonstiges
A Brighter Decade Ahead for Biotech - Industry Report Featuring Sareum
Holdings Plc and Angel Biotechnology Holdings Plc
03.03.2011 / 10:35
---------------------------------------------------------------------
Today, www.WorldStreetFundamentals.com released its industry report
highlighting Sareum (LSE: SAR) (ISIN: GB00B02RFS12) and Angel Biotechnology
Holdings Plc (LSE: ABH) (ISIN: GB00B0HZJ337). To read the full report,
visit www.WorldStreetFundamentals.com.
With the announcement of Pfizer's Sandwich facility planning on closing its
doors, attention to the biotech sector has been raised - along with many
eyebrows. There is quite a bit of speculation for the sector to be well on
its way with new markets emerging through 2015, money managers and sector
analysts alike see great opportunity about.
Biotech is enabling creation of new drugs at a faster pace than the
traditional pharmaceutical model and some believe that after a decade of
mediocre performance it is approaching an inflection point. Companies are
much more conducive to focusing on productivity and the sector is showing
signs of being back to top growth by 2013 due to the opportunity emerging
markets have created.
World Street Fundamentals has highlighted Sareum because of its positive
results in leukaemia studies from Aurora+FLT3 programme. Sareum has also
announced the recent placing to raise a further£500,000 providing
additional resources to accelerate the development of its Aurora+FLT3
programme and sufficient working capital for the foreseeable future.
Angel Biotechnology Holdings represents a diversified angle, as its
principal business is manufacturing and supplying materials for use in
early stage drug development and pre-clinical studies, along with drug
product and CMC documentation for Phases I, II and III clinical trials as
well as the manufacturing of licensed drugs or vaccines.
About World Street Fundamentals:
World Street Fundamentals is an online portal for professionals, investors
and new-comers to the markets to find in depth comprehensive research and
research tools to help guide you through the ever changing financial
markets around the world. Covering the top performers in the hottest
sectors and providing clarity to investors around the world.
Contact:
Adam Redford
editor@worldstreetfundamentals.com
www.WorldStreetFundamentals.com
Ende der Corporate News
---------------------------------------------------------------------
03.03.2011 Veröffentlichung einer Corporate News/Finanznachricht,übermittelt durch die DGAP - ein Unternehmen der EquityStory AG.
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber
verantwortlich.
Die DGAP Distributionsservices umfassen gesetzliche Meldepflichten,
Corporate News/Finanznachrichten und Pressemitteilungen.
Medienarchiv unter http://www.dgap-medientreff.de und
http://www.dgap.de
---------------------------------------------------------------------
114279 03.03.2011Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: EquityStory
" alt="Aben ernennt neue Mitglieder seines Board of Directors und meldet PrivatplatzierungDatum: 03.03.2011 - 10:35 Uhr
Sprache: Deutsch
News-ID 359831
Anzahl Zeichen: 3444
Kontakt-Informationen:
Kategorie:
Wirtschaft (allg.)
Diese Pressemitteilung wurde bisher 213 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: A Brighter Decade Ahead for Biotech - Industry Report Featuring Sareum Holdings Plc and Angel Biotechnology Holdings Plc"
steht unter der journalistisch-redaktionellen Verantwortung von
World Street Fundamentals (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
